Akira Tachibana
Papers
1
Total Citations
4
H-Index
1
About
Dr. Akira Tachibana is a leading urologic oncologist whose research centers on optimizing surgical outcomes for patients with localized prostate cancer, with a particular focus on the role of pelvic lymph node dissection during robot-assisted radical prostatectomy. His major contribution lies in rigorously evaluating the diagnostic and therapeutic benefits of limited versus extended lymph node dissection, providing critical evidence to guide surgical decision-making. In a landmark 2022 study employing propensity score matching, Dr. Tachibana demonstrated that extended dissection significantly improves detection of lymph node metastases (pN1), thereby enhancing staging accuracy and potentially influencing adjuvant therapy decisions. This work has garnered attention within the urology community, accumulating citations that underscore its clinical relevance. Dr. Tachibana’s research bridges the gap between surgical technique and patient outcomes, offering actionable insights for surgeons striving to balance oncologic efficacy with procedural morbidity. His dedication to evidence-based practice and meticulous methodology positions him as a key contributor to the evolution of minimally invasive prostate cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1